Pitch prize in Bordeaux.

Pitch prize in Bordeaux.

The MTHFD2 program is pitched by CEO Dr Ana Slipicevic at the Meet2Win conference in Bordeaux and wins a pitch price!
MTHFD2 inhibitors now published in Nature Cancer

MTHFD2 inhibitors now published in Nature Cancer

We are proud that the MTHFD2 inhibitors are now published in the prestigious journal Nature Cancer. In this first report, we describe that MTHFD2 inhibitors deplete cells of thymidine, specifically in cancer cells. We show that the loss of thymidine causes replication...
One-carbon therapeutics AB recieves SME status by EMA

One-carbon therapeutics AB recieves SME status by EMA

One-carbon therapeutics AB receives SME status by EMA The incentives offered by the SME Regulation give access to: Regulatory assistance: SMEs can benefit from direct regulatory assistance including SME briefing meetings, to provide guidance on the EU regulatory...